Expert Panel Hosts Follicular Lymphoma Symposium on September 15

In recognition of World Lymphoma Awareness Day on Saturday 15 September 2012, Rush University Cancer Center, Rush Medical Center, Chicago Blood Cancer Foundation and Hope for Lymphoma are hosting Follicular Lymphoma: On the Road to Cure, a patient and caregiver educational symposium held at Chicago's Searle Conference Center.

This symposium features some of the world's foremost experts on lymphoma. It is free, all you have to do is register.

TOPICS

The symposium's expert panel will discuss a variety of topics, including:

Follicular Lymphoma Basics by Brad S. Kahl MD, Chair of Lymphoma Research at University of Wisconsin Carbone Cancer Center.

Management of Symptomatic, High Tumor Burden, or Bulky Disease by Matthias J. Rummel MD of Justus-Liebig University Hospital and School of Medicine.

Is Watch & Wait Out of Date? by Parameswaran Venugopal, MD of Rush University Medical Center and others.

Latest Options for Relapse by Christopher Flowers MD of Emory University School of Medicine.

Progress in Stem Cell Transplantation by Dr. Flowers along with Henry C. Fung MD and Sunita Nathan MD of Rush University Medical Center.

The Winding Road: Our Journeys to Long Term Survival by author Betsy de Parry, who also hosts the PBS show Candid Cancer.

How Close Are We To Cure? by the Director of the Lymphoma Program at the Abramson Cancer Center of the University of Pennsylvania, Stephen J. Schuster MD. Dr. Schuster will be discussing the role of cancer vaccines such as Biovest's BiovaxID in lymphoma.

Managing Follicular Lymphoma for Long Term Optimal Survivorship by the symposium's panel of experts.

LIVESTREAM

You don't need to be in Chicago to get the most out of this incredible symposium--it will be livestreamed from the symposium's web site beginning at 9 AM central time.

Registration required, but it's still free!

More Articles

More Articles

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

Canine lymphoma, just like lymphoma in humans, can be separated into stages,...